MRI radiomics shows potential in determining breast cancer HER2 status
AuntMinnie
JANUARY 25, 2024
MRI radiomics features can differentiate breast cancers based on human epidermal growth factor receptors (HERs), according to research published January 24 in the American Journal of Roentgenology. Researchers led by Yuqin Peng from Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University in Guangzhou, Guangdong found that their nomogram based on MRI radiomics can distinguish HER2-zero from HER2-low or HER2-positives cancers, as well as HER2-low from HER2-positive cancers.
Let's personalize your content